Annexon to Participate in Upcoming September Investor Conferences
Fireside chats with CEO Douglas Love and live/archived webcasts for the Sept. 9–15 events will be on Annexon’s investor site.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Annexon (ANNX) will participate in three September 2026 healthcare investor conferences, featuring fireside chats with president and CEO Douglas Love.
Events include Wells Fargo on September 9 at 8:45 a.m. ET in Boston, Cantor on September 10 at 1:35 p.m. ET in New York, and H.C. Wainwright on September 15 at 1:00 p.m. ET in New York. Live and archived webcasts will be available on the company’s investor website.
Details
News Market Reaction – ANNX
On Sep 2, the day this news came out, ANNX closed 1.02% above the previous close. Argus tracked a trough of -13.5% from its starting point during tracking. Our momentum scanner recorded 2 alerts for this stock that day.
Data tracked by StockTitan Argus for the Sep 2 session.
Key Figures
- Wells Fargo conference
- 21st annual conference
- September 9, 2026, at 8:45 a.m. ET
- Cantor conference
- September 10, 2026
- 1:35 p.m. ET
- H.C. Wainwright conference
- 28th annual conference
- September 15, 2026, at 1:00 p.m. ET
- Replay availability
- 30 days
- Following the presentations
Historical Context
-
Inducement options covering 287,500 shares were granted to three new employees.
-
Quarterly results included a $55.3 million net loss and financing updates.
-
ARCHER II added a Month 24 dual primary endpoint and extension study.
-
Mark Blumenkranz joined the board as Muneer Satter resigned immediately.
-
Early FORWARD data showed rapid improvement in all ten treated patients.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BRISBANE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, Esq., president & chief executive officer, will participate in fireside chats during the following September investor conferences:
- Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 8:45 a.m. ET in Boston, MA; and,
- Cantor Global Healthcare Conference on Thursday, September 10, 2026, at 1:35 p.m. ET in New York, NY; and,
- H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15, 2026, at 1:00 p.m. ET in New York, NY.
Live webcasts of the presentations can be accessed under the ‘Events & Presentations’ section on the Investors page at annexonbio.com. Replays of the webcasts will be archived on the Annexon website for 30 days following the presentations.
About Annexon
Annexon Biosciences (Nasdaq: ANNX) is advancing the next generation platform of targeted immunotherapies for nearly 10 million people worldwide living with serious neuroinflammatory diseases. Our founding scientific approach focuses on C1q, the initiating molecule of a potent inflammatory pathway that when misdirected can lead to tissue damage and loss of function in a host of diseases. Our targeted therapies are designed to stop classical complement-driven neuroinflammation at its source to provide meaningful functional benefit and alter the course of disease. Annexon’s mission is to deliver game-changing therapies to patients so that they can live their best lives. To learn more visit annexonbio.com.
Investor Contact:
Joyce Allaire
LifeSci Advisors
jallaire@lifesciadvisors.com
Media Contact:
Beth Keshishian
917-912-7195
beth@bethkeshishian.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.